VitalConnect launches VistaTablet to further focus on growing at-home patient monitoring space

Company brings FDA cleared, clinical-grade and continuous monitoring to patients’ homes. VitalConnect, a player in wearable biosensor technology for wireless monitoring, announced the launch of VistaTabletTM, which ushers in the next-generation of its Vista SolutionTM platform for real-time patient monitoring.

VitalConnect is the digital health patient monitoring company with U.S. FDA clearance for both hospital and in-home solutions. The mobile interface of the VistaTablet offers healthcare providers and patients unprecedented access to vital sign data continuously acquired by the VitalPatch® wearable biosensor regardless of patient location. The VitalPatch biosensor is the smallest and lightest FDA-cleared Class 2 medical device that measures eight vital signs in real-time.

The VistaTablet is a handheld mobile relay device that securely hosts and transmits the vital signs measured by the VitalPatch biosensor, presenting this data locally for the patient and to healthcare providers through the Vista Solution platform. The mobility of the VistaTablet supports timely remote analysis by caregivers for patients regardless if they are in the hospital or at home. The Vista Solution platform allows physiological data for all patients to be easily accessible through the accompanying cloud-based application or viewed directly on the VistaTablet.

As a result of increasing healthcare costs, an increasing aging population (the number of 65 and over adults is expected to double by 2060), and demonstrated improved patient outcomes with advanced remote monitoring technologies, healthcare providers are beginning to shift eligible patients toward home care programs. Quality care traditionally found in a hospital has not been technologically or economically possible outside hospital walls on any significant scale until now. The Vista Solution, now with the mobile VistaTablet, helps change that paradigm, enabling at home programs to grow to meet the rising demands of quality home care. Within home care environments, “admit-to-home” patients receiving remote and continuous monitoring have shown a reduction in readmissions and an overall decrease in cost of care as compared to a traditional hospital stay. Enabling patients to be admitted to home, rather than lengthy hospital stays, has been shown to decrease healthcare costs while improving patient outcomes.

For acute care and the aging population, home hospital programs offer an affordable solution to healthcare that works for providers and patients,” said Dr. Nersi Nazari, PhD, CEO and founder of VitalConnect. “With the implementation of VistaTablet we are able to offer an easy-to-use mobile interface for physicians and patients to simultaneously monitor vital signs in real-time, allowing patients to recover at home while still under the care of their doctor.”

The launch of the VistaTablet device further extends the Vista Solution platform’s capabilities into use outside the hospital walls. Together, the VistaTablet and the VitalPatch biosensor offer the most discreet and comfortable monitoring solution to enhance patient care.